Elevance Health, Inc. (NYSE:ELV) Shares Purchased by Todd Asset Management LLC

Todd Asset Management LLC increased its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 16.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 59,906 shares of the company's stock after acquiring an additional 8,413 shares during the period. Todd Asset Management LLC's holdings in Elevance Health were worth $28,249,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. abrdn plc raised its stake in shares of Elevance Health by 86.8% during the fourth quarter. abrdn plc now owns 278,397 shares of the company's stock valued at $131,281,000 after acquiring an additional 129,364 shares during the last quarter. Cerity Partners LLC raised its stake in shares of Elevance Health by 21.3% during the fourth quarter. Cerity Partners LLC now owns 52,300 shares of the company's stock valued at $24,663,000 after acquiring an additional 9,199 shares during the last quarter. Wetzel Investment Advisors Inc. bought a new position in shares of Elevance Health during the fourth quarter valued at $218,000. Chicago Capital LLC raised its stake in shares of Elevance Health by 244.2% during the fourth quarter. Chicago Capital LLC now owns 7,028 shares of the company's stock valued at $3,314,000 after acquiring an additional 4,986 shares during the last quarter. Finally, Lecap Asset Management Ltd. bought a new position in shares of Elevance Health during the fourth quarter valued at $2,235,000. Institutional investors and hedge funds own 89.24% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ELV shares. Mizuho raised their price target on shares of Elevance Health from $575.00 to $585.00 and gave the company a "buy" rating in a research note on Wednesday, April 24th. Royal Bank of Canada lifted their target price on shares of Elevance Health from $574.00 to $575.00 and gave the stock an "outperform" rating in a research note on Friday, April 19th. Jefferies Financial Group lifted their target price on shares of Elevance Health from $602.00 to $604.00 and gave the stock a "buy" rating in a research note on Friday, April 19th. UBS Group lifted their target price on shares of Elevance Health from $585.00 to $605.00 and gave the stock a "buy" rating in a research note on Friday, April 19th. Finally, StockNews.com downgraded shares of Elevance Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, January 25th. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $587.42.

Elevance Health Stock Up 0.3 %

ELV traded up $1.35 during midday trading on Friday, hitting $526.96. The company had a trading volume of 819,445 shares, compared to its average volume of 1,136,492. Elevance Health, Inc. has a 52 week low of $412.00 and a 52 week high of $542.07. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $122.48 billion, a price-to-earnings ratio of 19.92, a PEG ratio of 1.16 and a beta of 0.79. The stock's 50 day moving average price is $513.54 and its 200 day moving average price is $489.21.

Elevance Health (NYSE:ELV - Get Free Report) last issued its quarterly earnings data on Thursday, April 18th. The company reported $10.64 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.54 by $0.10. The firm had revenue of $42.27 billion during the quarter, compared to analysts' expectations of $42.49 billion. Elevance Health had a net margin of 3.64% and a return on equity of 20.62%. The business's revenue was up .9% on a year-over-year basis. During the same period last year, the company earned $9.46 earnings per share. On average, research analysts anticipate that Elevance Health, Inc. will post 37.26 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be issued a dividend of $1.63 per share. This represents a $6.52 annualized dividend and a yield of 1.24%. The ex-dividend date is Monday, June 10th. Elevance Health's dividend payout ratio (DPR) is presently 24.64%.

Insider Buying and Selling

In related news, EVP Felicia F. Norwood sold 14,111 shares of the business's stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $533.74, for a total transaction of $7,531,605.14. Following the transaction, the executive vice president now directly owns 31,460 shares in the company, valued at $16,791,460.40. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Elevance Health news, Director Ramiro G. Peru sold 753 shares of Elevance Health stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $500.00, for a total value of $376,500.00. Following the sale, the director now owns 9,109 shares of the company's stock, valued at $4,554,500. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Felicia F. Norwood sold 14,111 shares of Elevance Health stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $533.74, for a total transaction of $7,531,605.14. Following the completion of the sale, the executive vice president now directly owns 31,460 shares in the company, valued at approximately $16,791,460.40. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.